期刊文献+

血管内皮生长因子诱导的胶质瘤源性微血管内皮细胞体外三维成型特性 被引量:2

VEGF-induced tubulogenesis of endothelial cells from human brain malignant glioma in the three dimentional model
原文传递
导出
摘要 目的比较人脑胶质瘤源性微血管内皮细胞(GDMEC)和内皮细胞样细胞ECV304三维培养血管生成特性,探讨GDMEC在血管生成研究中的意义。方法采用免疫磁珠分选系统获得纯化的人脑GDMEC,以胶原为介质建立内皮细胞三维培养模型,比较观察GDMEC与ECV304细胞三维培养小管样结构(TLS)形成及不同浓度血管内皮生长因子(VEGF)对两种细胞TLS形成的诱导作用。结果所获GDMEC细胞纯度达98%,可连续传代培养。GDMEC的TLS形成数显著多于同数量、同时相点ECV304细胞的TLS形成数量。VEGF在体外对GDMEC有显著的促进TLS形成作用,且呈量效和时效关系;VEGF对ECV304细胞形成小管样结构的诱导作用弱。结论GDMEC在体外保持了内皮细胞特征和活跃的血管生成特性,对VEGF的反应性较ECV304好,因而GDMEC更适合体外血管生成研究。 Objective To compare the tubulogenesis capability of malignant glioma-derived microvessel endothelial cells (GDMEC) from human brain with that of ECV304 cells in a three dimentional model and to explore the significance of GDMEC in the study on angiogenesis. Methods The GDMEC were isolated from malignant gliomas of human brain and purified by selectS, re binding to the monoclonal antibody against CD105 bound to the magnetic MACS MicroBeads. GDMEC and endothelial-like cell line ECV304 were compared with their capabilities of formatting tubule-like structure (TLS) in the three dimentional collagen matrix, with or without inducement by various concentration of vascular endothelial growth factor (VEGF). Results The obtained GDMEC had a high purification (98%) and could be successfully cultured in vitro. GDMECs formed more TLS than ECV304 cells of the same number and at the same time points. VEGF could induce rapid formation of TLS in a dose-dependent manner, however, ECV304 cells were less response to VEGF stimulation. Conclusions GDMEC could maintain their endothelial characteristics and potential capability of angiogenesis. They were more response to VEGF than ECV304, therefore, more suitable for in vitro studies on tumor angiogenesis.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2005年第9期579-582,共4页 Chinese Journal of Pathology
基金 国家自然科学基金资助项目(30270526 30370552)
  • 相关文献

参考文献10

  • 1Ribatti D, Nico B, Vacca A, et al. Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res, 2002,11 :81-90.
  • 2Aird WC. Endothelial cell heterogeneity. Grit Care Med, 2003, 31(4 Suppl) :S221-S230.
  • 3卞修武,杜琳琳,陈自强,史景泉,柳凤轩.星形细胞肿瘤血管生成活性和血管内皮生长因子与诱生型一氧化氮合酶表达的定量研究[J].中华病理学杂志,2001,30(1):23-26. 被引量:8
  • 4Bian XW, Chen JH, Jiang XF, et al. Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol, 2004, 4: 1537-1547.
  • 5Alessandri G, Chirivi RG, Castellani P, et al. Isolation and characterization of human tumor-derived capillary endothelial cells:role of oncofetal fibronectin. Lab Invest, 1995, 75 : 127-128.
  • 6Giordano F, Mitola S. Characterization of endothelial cells isolated by human meningiomas. J Neurosurg Sci, 2000, 44:177-185.
  • 7卞修武.血管生成、治疗性血管生成和抗血管生成[J].第三军医大学学报,2001,23(3):249-250. 被引量:20
  • 8Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med, 2003, 9: 669-676.
  • 9Hangai M, Kitaya N, Xu J, et al. Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis. Am J Pathol, 2002, 161:1429-1437.
  • 10Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys Acta, 2004, 1654 : 13-22.

二级参考文献17

  • 1Bian X W,Anal Quant Cytol Histol,2000年,22卷,267页
  • 2卞修武,中华病理学杂志,1999年,28卷,178页
  • 3Gasparini G,Oncology,2001年,60卷,1期,72页
  • 4Bian X W,Anal Quant Cytol Histol,2000年,22卷,3期,267页
  • 5Fidler I J,Cancer J Sci Am,2000年,6卷,Suppl 2期,S134页
  • 6Simons M,Circulation,2000年,102卷,11期,E73页
  • 7Griffioen A W,Pharmacol Rev,2000年,52卷,2期,237页
  • 8卞修武,国家自然科学基金资助项目研究成果年报·生命科学1999,2000年,33页
  • 9卞修武,第三军医大学学报,1995年,17卷,4期,344页
  • 10卞修武,史景泉.血管内皮生长因子及其受体在肿瘤血管生成中的作用及与抗血管生成研究进展[J].中华病理学杂志,1997,26(4):248-250. 被引量:18

共引文献25

同被引文献23

  • 1安继红,陈鹏,辛秀芹.姜黄素体外抗肿瘤作用的观察[J].实用临床医药杂志,2007,11(2):24-25. 被引量:10
  • 2Raspollini M R, Taddei G L. Tumor markers in ovarian carcinoma[ J]. Int J Gynaecol Obstet, 2007, 97(3 ) : 175 - 181.
  • 3McKenzie E A. Heparanase: a target for drug discovery in cancer and inflammation[ J]. Br J Pharmacol, 2007, 151 ( 1 ) : 1 - 14.
  • 4Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis[ J]. Int J Biochem Cell Biol, 2006, 38(12) : 2018 - 2039.
  • 5Miao H Q, Liu H, Navarro E, et al. Development of heparanase inhibitors for anti-cancer therapy[J]. Curr Med Chem, 2006, 13(18) : 2101 -2111.
  • 6Yekkata K, Baudino T A. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/ + mice due to decreases in c-Myc expression [ J]. Mol Cancer Res, 2007, 5 (12) : 1296 - 1303.
  • 7Xu X, Wang B, Ye C, et al. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer [ J ]. Cancer Lett, 2008, 261 (2) : 147 - 157.
  • 8Esmat A, El-Demerdash E, El-Mesallamy H, et al. Toxicity and oxidative stress of acrylonitrile in rat primary glial cells: preventive effects of N-acetylcysteine [ J ]. Toxicol Lett, 2007, 171 (3) : 111 - 118.
  • 9Sohn J H, Han K L, Choo J H, et al. Macelignan protects HepG2 cells against tert-butylhydroperoxide-induced oxidative damage [ J ]. Biofactors, 2007, 29(1) : 1 -10.
  • 10Cheng Y, Kozubek A, Ohlsson L, et al. Curcumin decreases acid sphingomyelinase activity in colon cancer Caco-2 cells [ J ]. Planta Med, 2007, 73 (8) : 725 - 730.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部